Shandong Linuo Pharmaceutical Packaging (301188.SZ) plans to establish a holding subsidiary in Brazil to expand into overseas markets.

Shandong Linuo Pharmaceutical Packaging (301188.SZ) announced that on March 10, 2025, the company signed a "Cooperation Investment Agreement" with SANTISA LABORATRIO FARMACUTICO S/A (referred to as "SANTISA") in Jinan, Shandong, China. Both parties intend to jointly establish Linuo Pharmaceutical Packaging Brazil Limited Company (tentative name, referred to as "Brazil Drug Packaging") in Brazil, with the business scope of producing and selling pharmaceutical packaging products, including ampoules and vials. The registered capital of Brazil Drug Packaging is 2 million US dollars, of which the company will hold 75% of the shares and SANTISA will hold 25% of the shares. This matter will benefit the company in further expanding its overseas market and deepening cooperation with international customers.